Maze Therapeutics targets up to $728 mln valuation in US IPO
Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...
ENDPOINTS NEWS1h
Maze looks to lead IPO queue with $113M Nas­daq de­but
Maze Therapeutics is eyeing a $113 million initial public offering a little under two months after revealing a $115 million ...
Soap's maze-solving skills could unlock secrets of the human body
An international team of scientists have discovered that soap could be important to helping our understanding of complex ...
Coder creates an 'infinite maze' to snare AI bots in an act of 'sheer unadulterated rage at how things are going' on the content-scraped web
An anonymous coder, writing to 404media under the fake name Aaron B, has also been feeling the malaise, and he's doing ...
Rock Paper Shotgun13d
You’ve probably played 2005’s most experimental horror game
One unsung jump scare game in particular pioneered horror in the internet age, blazing everywhere from nascent social media ...
autoevolution5d
Watch YangWang U7 Flagship Sedan Using Its Body Control System To Complete a Maze Game
BYD shared a video showing the YangWang U7 leveraging the Disus-Z suspension system to complete a maze game via phone control ...
Maze Therapeutics targets up to $728 million valuation in US IPO
(Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial public offering in the United States. The South San Francisco, ...